Cargando…
Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
BACKGROUND: Patients who have had a venous thromboembolic event are generally advised to receive anticoagulant treatment for 3 months or longer to prevent a recurrent episode. Current guidelines recommend initial heparin and an oral vitamin K antagonist (VKA) for long-term anticoagulation. However,...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754098/ https://www.ncbi.nlm.nih.gov/pubmed/26929637 http://dx.doi.org/10.2147/VHRM.S88088 |